DORIS DEE FLEMING: Open Payments
NPI 1386002038 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 32 payments from 10 companies in 2025. Trend: 2023 $304 · 2024 $726 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 11 | $192 |
| ABBVIE INC. | 6 | $174 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Novo Nordisk Inc | 4 | $69 |
| Kowa Pharmaceuticals America, Inc. | 2 | $48 |
| Lilly USA, LLC | 1 | $30 |
| Genentech USA, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $18 |
Products named: VRAYLAR, The Cologuard Plus Collection Kit, Cologuard Collection Kit, REXULTI, Wegovy, ZORYVE, MOUNJARO, Ocrevus Zunovo.
Industry payments across OR — which companies pay providers there.
